Assessment and Treat Neglect Patients With a VR Application
Launched by UNIVERSITEIT ANTWERPEN · May 22, 2025
Trial Information
Current as of August 19, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new way to help stroke patients who experience neglect, a condition where they may not notice or pay attention to one side of their body or environment. The researchers are testing a virtual reality (VR) application called "SpatialSense" to see if it can improve recovery compared to regular therapy. Patients in the study will receive standard occupational and physical therapy but will replace part of that treatment with VR sessions three times a week for four weeks. The goal is to find out if using the VR app can help improve balance, daily living skills, and overall quality of life.
To be eligible for this trial, participants need to be at least 18 years old and have had a hemispheric stroke. They should also be able to give their consent to participate. However, people with certain severe mental health issues, specific neurodegenerative diseases, or certain medical implants will not be eligible. This trial has not started recruiting participants yet, but if you or a loved one meets the criteria, this could be an exciting opportunity to explore a new approach to rehabilitation.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Age 18 years or older
- • 2. Able to provide informed consent
- • 3. have had a hemispheric stroke
- Exclusion Criteria:
- • 1. Have a severe comorbid psychiatric (E.g. psychotic symptoms) disorder
- • 2. Have a premorbid neurodegenerative disease (E.g. Alzheimer's dementia, vascular dementia)
- • 3. Have severe written language comprehension deficits
- • 4. Have a medical implant, such as a cochlear implant or a pacemaker
- • 5. Have a severe visual impairment that cannot be corrected by wearing glasses while training
- • 6. Have a history of epileptic seizures The following exclusion criteria do not apply to the Non-VSN stroke group.
- • 7. Do not show signs of a spatial asymmetry in performance on a battery of screening tasks
- • 8. Having visual field deficits or lesions in the occipital lobe
About Universiteit Antwerpen
The University of Antwerp is a leading research institution based in Belgium, renowned for its commitment to advancing knowledge and innovation in various scientific fields. With a strong emphasis on interdisciplinary collaboration, the university actively engages in clinical trials that aim to improve healthcare outcomes and enhance understanding of complex medical conditions. The University of Antwerp's dedicated research teams leverage cutting-edge methodologies and state-of-the-art facilities to conduct rigorous studies, ensuring adherence to the highest ethical standards and regulatory requirements. Through its clinical trial initiatives, the university strives to translate research findings into practical applications that benefit patients and contribute to the broader medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Antwerpen, , Belgium
Patients applied
Trial Officials
Wim Saeys
Study Chair
+32 496804347
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported